Propel Bio Management, LLC
Top Portfolio Positions
38 positions ·
$158,680,481 total
· as of Mar 31, 2026
| Ticker | Company | Shares | Value (USD) | % of Portfolio | Open |
|---|---|---|---|---|---|
| PAGP |
Plains Gp Holdings LP
Energy
|
1,272,360 | $30,892,900 | 19.47% | |
| ACHV |
Achieve Life Sciences, Inc.
Healthcare
|
3,786,425 | $11,132,089 | 7.02% | |
| PHAT |
Phathom Pharmaceuticals, Inc.
Healthcare
|
841,272 | $9,346,531 | 5.89% | |
| DCTH |
Delcath Systems, Inc.
Healthcare
|
979,698 | $9,091,597 | 5.73% | |
| CORT |
Corcept Therapeutics Inc
Healthcare
|
147,828 | $5,958,946 | 3.76% | |
| ABEO |
Abeona Therapeutics Inc.
Healthcare
|
1,329,899 | $5,957,947 | 3.75% | |
| VOR |
Vor Biopharma Inc.
Healthcare
|
314,543 | $5,611,447 | 3.54% | |
| KYTX |
Kyverna Therapeutics, Inc.
Healthcare
|
644,421 | $5,561,353 | 3.50% | |
| MIST |
Milestone Pharmaceuticals Inc.
Healthcare
|
4,118,321 | $4,900,801 | 3.09% | |
| CLDX |
Celldex Therapeutics, Inc.
Healthcare
|
131,364 | $4,166,866 | 2.63% |
Portfolio Trend
10 quarters · across all stocks
Holdings in ABEO
Shares Held
Position Value (USD)
8 quarters on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $5,957,947 | 1,329,899 | Shares | Defined | 2026-05-14 | |
| 2025-12-31 | $4,378,210 | 830,780 | Shares | Defined | 2026-02-11 | |
| 2025-09-30 | $5,142,836 | 974,022 | Shares | Defined | 2025-11-12 | |
| 2025-06-30 | $5,532,444 | 974,022 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $2,970,344 | 624,022 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $3,475,802 | 624,022 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $3,943,819 | 624,022 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $5,291,706 | 1,248,044 | Shares | Defined | 2024-08-12 | |
| No 13F history on record for this holder in this stock. | ||||||